npj Breast Cancer : Impact Factor & More
eISSN: 2374-4677pISSN: 2374-4677
Open AccessShare this on:
Key Metrics
CiteScore 
6.5
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.73
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on npj Breast Cancer
npj Breast Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2890 | USD 3390 | GBP 2590 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Breast Cancer Research Foundation |
| Frequency | Continuous publication |
| Publication Start Year | 2015 |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in npj Breast Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in npj Breast Cancer
Multi-omics analysis in suspected hereditary breast and ovarian cancer cases reveals novel candidate susceptibility factors.
- 30 Jun 2026
- NPJ breast cancer
Flavonoid-rich foods, genetic risk, and female breast cancer risk: a prospective cohort study.
- 30 Jun 2026
- NPJ breast cancer
ACSS2-mediated metabolic-epigenetic crosstalk drives Fulvestrant resistance and represents a novel therapeutic target.
- 27 Jun 2026
- NPJ breast cancer
Patient-reported outcomes as early indicators of recurrence, disease progression, and survival via machine learning in breast cancer.
- 27 Jun 2026
- NPJ breast cancer
Anlotinib-containing regimens in HR+ advanced breast cancer after prior CDK4/6 inhibitor progression.
- 24 Jun 2026
- NPJ breast cancer
Multimodal imaging and artificial intelligence for response assessment to neoadjuvant therapy in breast cancer: a comprehensive review.
- 24 Jun 2026
- NPJ breast cancer
Multi-omics analysis in suspected hereditary breast and ovarian cancer cases reveals novel candidate susceptibility factors.
- 30 Jun 2026
- NPJ breast cancer
Flavonoid-rich foods, genetic risk, and female breast cancer risk: a prospective cohort study.
- 30 Jun 2026
- NPJ breast cancer
ACSS2-mediated metabolic-epigenetic crosstalk drives Fulvestrant resistance and represents a novel therapeutic target.
- 27 Jun 2026
- NPJ breast cancer
Patient-reported outcomes as early indicators of recurrence, disease progression, and survival via machine learning in breast cancer.
- 27 Jun 2026
- NPJ breast cancer
Anlotinib-containing regimens in HR+ advanced breast cancer after prior CDK4/6 inhibitor progression.
- 24 Jun 2026
- NPJ breast cancer
Multimodal imaging and artificial intelligence for response assessment to neoadjuvant therapy in breast cancer: a comprehensive review.
- 24 Jun 2026
- NPJ breast cancer
FAQs on npj Breast Cancer
How long has npj Breast Cancer been actively publishing? 
What is the publishing frequency of npj Breast Cancer?
How many articles did npj Breast Cancer publish last year?
What is the eISSN & pISSN for npj Breast Cancer?
What is Citescore for npj Breast Cancer?
What is SNIP score for npj Breast Cancer?
What is the SJR for npj Breast Cancer?
Who is the publisher of npj Breast Cancer?
